Aldeyra Therapeutics, Inc. (ALDX)
USD 1.81
(27.41%)
USD 1.81
(27.41%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -127.16 Million USD | 0.91% |
| 2022 | -128.33 Million USD | 40.01% |
| 2021 | -213.93 Million USD | -242.12% |
| 2020 | -62.53 Million USD | -110.75% |
| 2019 | -29.67 Million USD | 37.35% |
| 2018 | -47.35 Million USD | -153.43% |
| 2017 | -18.68 Million USD | -74.66% |
| 2016 | -10.69 Million USD | 19.92% |
| 2015 | -13.36 Million USD | -83.66% |
| 2014 | -7.27 Million USD | -265.51% |
| 2013 | -1.99 Million USD | -151.69% |
| 2012 | -790.71 Thousand USD | -140.57% |
| 2011 | 1.94 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -15.39 Million USD | 58.21% |
| 2024 Q1 | -36.83 Million USD | 71.03% |
| 2023 FY | -127.16 Million USD | 0.91% |
| 2023 Q2 | -135.52 Million USD | 8.99% |
| 2023 Q4 | -127.16 Million USD | -0.01% |
| 2023 Q3 | -127.15 Million USD | 6.18% |
| 2023 Q1 | -148.91 Million USD | -16.04% |
| 2022 Q1 | -143.02 Million USD | 33.15% |
| 2022 FY | -128.33 Million USD | 40.01% |
| 2022 Q4 | -128.33 Million USD | -13.86% |
| 2022 Q3 | -112.71 Million USD | -7.24% |
| 2022 Q2 | -105.1 Million USD | 26.52% |
| 2021 Q3 | -225.54 Million USD | 3.73% |
| 2021 Q2 | -234.28 Million USD | -90.43% |
| 2021 FY | -213.93 Million USD | -242.12% |
| 2021 Q1 | -123.03 Million USD | -96.75% |
| 2021 Q4 | -213.93 Million USD | 5.15% |
| 2020 Q3 | -71.16 Million USD | -55.51% |
| 2020 FY | -62.53 Million USD | -110.75% |
| 2020 Q4 | -62.53 Million USD | 12.13% |
| 2020 Q2 | -45.76 Million USD | -93.08% |
| 2020 Q1 | -23.7 Million USD | 20.12% |
| 2019 Q3 | -36.93 Million USD | 5.46% |
| 2019 FY | -29.67 Million USD | 37.35% |
| 2019 Q2 | -39.07 Million USD | 11.04% |
| 2019 Q4 | -29.67 Million USD | 19.68% |
| 2019 Q1 | -43.91 Million USD | 7.26% |
| 2018 Q3 | -16.66 Million USD | 28.38% |
| 2018 Q2 | -23.26 Million USD | -18.54% |
| 2018 Q1 | -19.62 Million USD | -5.01% |
| 2018 FY | -47.35 Million USD | -153.43% |
| 2018 Q4 | -47.35 Million USD | -184.25% |
| 2017 Q1 | -17.98 Million USD | -68.07% |
| 2017 Q3 | -31.77 Million USD | -139.19% |
| 2017 Q2 | -13.28 Million USD | 26.13% |
| 2017 Q4 | -18.68 Million USD | 41.18% |
| 2017 FY | -18.68 Million USD | -74.66% |
| 2016 Q4 | -10.69 Million USD | 19.31% |
| 2016 Q3 | -13.25 Million USD | 18.68% |
| 2016 Q2 | -16.3 Million USD | -84.18% |
| 2016 Q1 | -8.85 Million USD | 33.74% |
| 2016 FY | -10.69 Million USD | 19.92% |
| 2015 FY | -13.36 Million USD | -83.66% |
| 2015 Q4 | -13.36 Million USD | 54.46% |
| 2015 Q3 | -29.33 Million USD | 9.17% |
| 2015 Q2 | -32.29 Million USD | -123.38% |
| 2015 Q1 | -14.45 Million USD | -98.76% |
| 2014 Q2 | -10.31 Million USD | -1212.96% |
| 2014 Q4 | -7.27 Million USD | 18.28% |
| 2014 Q3 | -8.9 Million USD | 13.69% |
| 2014 Q1 | -785.46 Thousand USD | 60.53% |
| 2014 FY | -7.27 Million USD | -265.51% |
| 2013 Q4 | -1.99 Million USD | 17.55% |
| 2013 Q3 | -2.41 Million USD | 0.0% |
| 2013 Q1 | 1223.64 USD | 100.15% |
| 2013 FY | -1.99 Million USD | -151.69% |
| 2012 Q4 | -790.71 Thousand USD | 0.0% |
| 2012 FY | -790.71 Thousand USD | -140.57% |
| 2011 FY | 1.94 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -127.325% |
| Alkermes plc | -166.73 Million USD | 23.734% |
| Agenus Inc. | 274.13 Million USD | 146.388% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 106.801% |
| Aptorum Group Limited | 1.35 Million USD | 9470.77% |
| Ardelyx, Inc. | 34.51 Million USD | 468.468% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 3071.16% |
| Bicycle Therapeutics plc | -481.46 Million USD | 73.588% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 451.646% |
| ChromaDex Corporation | -24.04 Million USD | -428.799% |
| Chimerix, Inc. | -25.51 Million USD | -398.357% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1924.975% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -437.085% |
| CRISPR Therapeutics AG | -150.84 Million USD | 15.698% |
| Precision BioSciences, Inc. | -85.41 Million USD | -48.888% |
| Dyadic International, Inc. | -6.37 Million USD | -1893.786% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -698.128% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1759.043% |
| Lantern Pharma Inc. | -21.7 Million USD | -485.928% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -15.044% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1388.506% |
| Incyte Corporation | -3.17 Billion USD | 95.995% |
| IO Biotech, Inc. | -140.69 Million USD | 9.619% |
| Jaguar Health, Inc. | 29.39 Million USD | 532.669% |
| Novavax, Inc. | -298.29 Million USD | 57.369% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2482.718% |
| Opthea Limited | 28.15 Million USD | 551.624% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -657.434% |
| ContextLogic Inc. | -232 Million USD | 45.187% |
| MiMedx Group, Inc. | -33.9 Million USD | -275.109% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1347.334% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -5388.311% |
| NextCure, Inc. | -6.47 Million USD | -1863.342% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -151.808% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1893.505% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1145.489% |
| Vaxcyte, Inc. | -368.22 Million USD | 65.465% |
| PDS Biotechnology Corporation | -32.7 Million USD | -288.78% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 835.998% |
| Pharming Group N.V. | 109.8 Million USD | 215.811% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -631.005% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 27.429% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -586.645% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -586.645% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1691.066% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2070.062% |
| Acelyrin, Inc. | -216.9 Million USD | 41.372% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2166.66% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -7276.198% |
| Summit Therapeutics Inc. | 34.67 Million USD | 466.746% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1769.259% |
| Senti Biosciences, Inc. | 1.74 Million USD | 7408.371% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 31.115% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -64.189% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -1997.751% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 127560.089% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 20349.308% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -8.646% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 24.411% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 214.698% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1574.113% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 1.509% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 1944.425% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 47.531% |
| Immix Biopharma, Inc. | -17.5 Million USD | -626.255% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 59.847% |
| MEI Pharma, Inc. | -3.7 Million USD | -3332.271% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1116.431% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 178.623% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 557.546% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1759.043% |
| Precigen, Inc. | -481 Thousand USD | -26337.766% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1003.101% |
| AlloVir, Inc. | -62.69 Million USD | -102.842% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -128.658% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 306.217% |
| ImmuCell Corporation | 10.99 Million USD | 1257.044% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 17.503% |
| Onconetix, Inc. | 5.33 Million USD | 2485.204% |
| PureTech Health plc | -167.19 Million USD | 23.943% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -317.484% |
| Elevation Oncology, Inc. | -19.11 Million USD | -565.162% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2490.459% |
| Seer, Inc. | -4.24 Million USD | -2899.19% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -429.041% |
| Innoviva, Inc. | 255.56 Million USD | 149.759% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -127.634% |
| ESSA Pharma Inc. | -33.62 Million USD | -278.226% |
| GlycoMimetics, Inc. | -40.98 Million USD | -210.278% |
| GT Biopharma, Inc. | -1.02 Million USD | -12355.01% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -87.607% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 307.594% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 5.156% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -817.766% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -340.446% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -168702.474% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -312.046% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1451.774% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -3964.076% |
| Soligenix, Inc. | -4.95 Million USD | -2468.175% |
| Century Therapeutics, Inc. | 847 Thousand USD | 15113.655% |
| Kura Oncology, Inc. | -20.11 Million USD | -532.099% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -210.721% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1414.237% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 7080.623% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -3877.656% |
| Autolus Therapeutics plc | -186.59 Million USD | 31.851% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -157.922% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 53.891% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 471.092% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 177.366% |
| GRI Bio, Inc. | -1.79 Million USD | -6988.387% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1315.618% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -282.373% |
| IGM Biosciences, Inc. | -72.6 Million USD | -75.145% |
| INmune Bio, Inc. | -25.41 Million USD | -400.435% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 184.243% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -151.023% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -682.588% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -4307.935% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 434.514% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -208.767% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 498.826% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 133.646% |
| Verastem, Inc. | -37.27 Million USD | -241.128% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1301.583% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -145.2% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -740.209% |
| Histogen Inc. | -7.48 Million USD | -1598.486% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -488.544% |
| Surrozen, Inc. | -32.66 Million USD | -289.314% |
| Organovo Holdings, Inc. | -1.5 Million USD | -8338.332% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2925.241% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 770.698% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 4961.072% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 3159.809% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1417.282% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -192.725% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -772.38% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 59.858% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -17511.508% |
| Apollomics, Inc. | -27.39 Million USD | -364.193% |
| Amarin Corporation plc | -191.04 Million USD | 33.435% |
| Mesoblast Limited | 55.96 Million USD | 327.232% |
| Turnstone Biologics Corp. | -14.58 Million USD | -771.953% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -402.79% |
| Synaptogenix, Inc. | -28.66 Million USD | -343.681% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -13486.074% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 360.949% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -14650.873% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1650.127% |
| Exelixis, Inc. | -73.05 Million USD | -74.08% |
| Better Therapeutics, Inc. | -860 Thousand USD | -14686.704% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -429.57% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 47.315% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 17376.393% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1609.644% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 10240.802% |
| Gritstone bio, Inc. | 39.49 Million USD | 422.02% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -51.206% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -4731.265% |
| Avid Bioservices, Inc. | 169.72 Million USD | 174.923% |
| Insmed Incorporated | 721.62 Million USD | 117.622% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1291.079% |
| MediWound Ltd. | -5.32 Million USD | -2289.434% |
| OmniAb, Inc. | 9.2 Million USD | 1481.785% |
| Alector, Inc. | -35.63 Million USD | -256.836% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 247.917% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2480.472% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1060.538% |
| Zai Lab Limited | -775 Million USD | 83.592% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 137.341% |
| Aura Biosciences, Inc. | -21.52 Million USD | -490.781% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -54.178% |
| Immunic, Inc. | -45.34 Million USD | -180.471% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 34.184% |
| Veracyte, Inc. | -203.82 Million USD | 37.61% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 119.923% |
| FibroGen, Inc. | 56.76 Million USD | 324.013% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1528.025% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -4398.124% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -6042.236% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.77% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -3706.215% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 23.378% |
| TG Therapeutics, Inc. | 17.86 Million USD | 811.934% |
| Galecto, Inc. | -21.21 Million USD | -499.386% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -434.646% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 108.103% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -419.637% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1005.116% |
| XBiotech Inc. | -200.02 Million USD | 36.424% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -51.206% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 2908.429% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -260.621% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -64.684% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2334.505% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 25.379% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -37.664% |
| Vaxxinity, Inc. | 10.13 Million USD | 1355.089% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 117.272% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1081.008% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -92.804% |
| NexImmune, Inc. | -3.13 Million USD | -3958.077% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -3583.107% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -741.519% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -369.246% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1316.721% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -101979.595% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -213.432% |
| Ainos, Inc. | 4.07 Million USD | 3218.389% |
| Pluri Inc. | 22.82 Million USD | 657.036% |
| Prothena Corporation plc | -608.34 Million USD | 79.097% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -7.081% |
| Celularity Inc. | 65.19 Million USD | 295.069% |
| Rallybio Corporation | -24.1 Million USD | -427.615% |
| Cue Biopharma, Inc. | -33.81 Million USD | -276.018% |
| MeiraGTx Holdings plc | -40.3 Million USD | -215.532% |
| Omeros Corporation | 331.17 Million USD | 138.398% |
| Humacyte, Inc. | -22.48 Million USD | -465.533% |
| Immunocore Holdings plc | -358.59 Million USD | 64.538% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -417.459% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -311.526% |
| Blueprint Medicines Corporation | 702.83 Million USD | 118.093% |
| CalciMedica, Inc. | -5.53 Million USD | -2199.56% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 32.438% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1145.013% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -217.62% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -282.419% |
| Pulmatrix, Inc. | -10.41 Million USD | -1120.751% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2027.583% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -233.401% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -14.15% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -112.141% |
| Cytokinetics, Incorporated | 642.37 Million USD | 119.796% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2083.851% |
| Nutriband Inc. | -251.65 Thousand USD | -50431.341% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -272.712% |
| Vor Biopharma Inc. | 4.3 Million USD | 3057.341% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.893% |
| Evogene Ltd. | -19.63 Million USD | -547.681% |
| ProKidney Corp. | -56.23 Million USD | -126.129% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -161.271% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1276.671% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 109.324% |
| CorMedix Inc. | -43.05 Million USD | -195.373% |
| BioLineRx Ltd. | 7.33 Million USD | 1833.447% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -363.01% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 375.566% |
| Atai Life Sciences N.V. | -28.55 Million USD | -345.289% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 5801.143% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -457.353% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 817.032% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -69.387% |
| MediciNova, Inc. | -50.78 Million USD | -150.407% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -61.367% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -565206.317% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1870.77% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 36.36% |
| Biomea Fusion, Inc. | -166.57 Million USD | 23.656% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 28.948% |
| Mereo BioPharma Group plc | -51.46 Million USD | -147.072% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -34.079% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 56.711% |
| Absci Corporation | -72.59 Million USD | -75.164% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2885.056% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 45.757% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -34.98% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -32.885% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -225.457% |
| Allakos Inc. | -24.97 Million USD | -409.172% |
| Imunon, Inc. | -4.21 Million USD | -2917.801% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -762.608% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 6.081% |
| BioAtla, Inc. | -109.01 Million USD | -16.654% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 17376.393% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -13442.668% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1162.725% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -499.753% |
| XOMA Corporation | -29 Million USD | -338.502% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -667.909% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1310.444% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1607.151% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -2.03% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 38.911% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -55.499% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -37.087% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -14700.748% |
| Akari Therapeutics, Plc | -3.84 Million USD | -3207.299% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 7935.753% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 109.209% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -10602.964% |
| UroGen Pharma Ltd. | 4.39 Million USD | 2996.052% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 212.059% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 176812.231% |
| Orgenesis Inc. | 21.78 Million USD | 683.757% |
| Entera Bio Ltd. | -10.62 Million USD | -1096.403% |
| GH Research PLC | -78.07 Million USD | -62.872% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -470.557% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -377.008% |
| Xencor, Inc. | 29.64 Million USD | 528.976% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -6355.726% |
| Replimune Group, Inc. | 1.41 Million USD | 9106.066% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -51823.847% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -0.592% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -10602.964% |
| Portage Biotech Inc. | -4.98 Million USD | -2453.015% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -565206.317% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -92.32% |
| OncoCyte Corporation | -6.56 Million USD | -1837.615% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 14270.249% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2691.388% |
| Purple Biotech Ltd. | -14.13 Million USD | -799.46% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -435.299% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1842.944% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -661.828% |
| HilleVax, Inc. | -165.48 Million USD | 23.156% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -4910.467% |
| Tharimmune, Inc. | -10.93 Million USD | -1062.886% |
| Genprex, Inc. | -6.73 Million USD | -1787.395% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 65.52% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -43.755% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -8976.778% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -3733.817% |
| OKYO Pharma Limited | -826.84 Thousand USD | -15279.569% |
| Savara Inc. | 153 Thousand USD | 83214.808% |
| Curis, Inc. | -23.88 Million USD | -432.363% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2365.449% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -16287.073% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -1948.416% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 10831.279% |
| BeiGene, Ltd. | -2.25 Billion USD | 94.356% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1130.641% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 79.092% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 31.479% |
| Erasca, Inc. | -37.21 Million USD | -241.696% |
| bluebird bio, Inc. | 108.57 Million USD | 217.127% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -9773.93% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 133.575% |
| DBV Technologies S.A. | -126.98 Million USD | -0.141% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -9773.93% |
| Moderna, Inc. | -2.9 Billion USD | 95.626% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1128.416% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1070.093% |
| Molecular Templates, Inc. | 707 Thousand USD | 18086.656% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -305.361% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 136.689% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -54.963% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -38.63% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -294.043% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -269.926% |
| MacroGenics, Inc. | -66.98 Million USD | -89.842% |
| RenovoRx, Inc. | -1.17 Million USD | -10741.062% |
| Adicet Bio, Inc. | -138.78 Million USD | 8.374% |
| Prime Medicine, Inc. | -27.94 Million USD | -355.122% |
| Aditxt, Inc. | 18.12 Million USD | 801.763% |
| Adagene Inc. | -87.62 Million USD | -45.121% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2952.883% |
| Quantum-Si incorporated | -118.55 Million USD | -7.261% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 453.189% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1601.398% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -162.149% |
| SciSparc Ltd. | -2.06 Million USD | -6058.143% |
| Vericel Corporation | 1.27 Million USD | 10058.156% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -960.447% |
| Minerva Neurosciences, Inc. | 41 Million USD | 410.128% |
| Generation Bio Co. | 31.44 Million USD | 504.368% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 27.485% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -311.233% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 209.068% |
| Invivyd, Inc. | -198.47 Million USD | 35.929% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -40.873% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -5203.678% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -79.638% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1763.233% |
| 2seventy bio, Inc. | 181.71 Million USD | 169.981% |
| ADMA Biologics, Inc. | 90.06 Million USD | 241.192% |
| Clene Inc. | 3.34 Million USD | 3907.355% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1300.086% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -491.166% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1870.77% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 63.047% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -389.105% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 171.576% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -3007.994% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 2642.296% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2341.268% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 2.408% |
| Evaxion Biotech A/S | 5.28 Million USD | 2505.323% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -12.968% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 3.129% |
| Trevena, Inc. | 2.25 Million USD | 5731.783% |
| Surrozen, Inc. | -32.66 Million USD | -289.314% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -146.876% |
| Cingulate Inc. | 3.08 Million USD | 4225.162% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -4229.781% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1869.384% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1268.664% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -60.314% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 3.261% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -20.488% |
| Clearmind Medicine Inc. | -3.94 Million USD | -3125.396% |
| Kronos Bio, Inc. | -36.05 Million USD | -252.709% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1451.532% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 8821.165% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -134.381% |
| Statera Biopharma, Inc. | 14.41 Million USD | 982.09% |
| ImmunityBio, Inc. | 618.22 Million USD | 120.57% |
| Korro Bio, Inc. | -132.94 Million USD | 4.346% |
| Kineta, Inc. | -4.54 Million USD | -2700.389% |
| BioVie Inc. | -17.73 Million USD | -617.139% |
| Codexis, Inc. | -43.27 Million USD | -193.882% |
| Celularity Inc. | 65.19 Million USD | 295.069% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -3912.801% |
| Celcuity Inc. | 6.78 Million USD | 1974.629% |
| Virax Biolabs Group Limited | -3.36 Million USD | -3679.131% |
| Cibus, Inc. | -8.07 Million USD | -1474.222% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -2906.991% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 2882.618% |
| IN8bio, Inc. | -16.38 Million USD | -675.921% |
| Kodiak Sciences Inc. | -103.87 Million USD | -22.422% |
| Annexon, Inc. | -193.75 Million USD | 34.368% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 353337.933% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -626.702% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -3519.859% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 112.062% |
| Eyenovia, Inc. | 1.25 Million USD | 10202.92% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 572.647% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3821.235% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -282.488% |
| Arcellx, Inc. | -296.95 Million USD | 57.177% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -551.931% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -115.993% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -513.527% |
| Moolec Science SA | 117.61 Thousand USD | 108219.351% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -231.169% |
| Geron Corporation | 14.76 Million USD | 961.498% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -235.37% |
| Royalty Pharma plc | 5.65 Billion USD | 102.247% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 10.08% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1719.401% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2271.229% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 9.639% |
| Humacyte, Inc. | -22.48 Million USD | -465.533% |
| Structure Therapeutics Inc. | -124.33 Million USD | -2.273% |
| 89bio, Inc. | -289.05 Million USD | 56.006% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -403.786% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -7032.118% |
| Genelux Corporation | -6.89 Million USD | -1743.248% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -309.433% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 252.114% |
| Notable Labs, Ltd. | -9.77 Million USD | -1200.794% |
| Liquidia Corporation | -80.17 Million USD | -58.608% |
| Mustang Bio, Inc. | -3.73 Million USD | -3303.792% |
| Immunovant, Inc. | -635.22 Million USD | 79.981% |
| Quantum-Si incorporated | -118.55 Million USD | -7.261% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -624.013% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -2969.41% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1684.224% |
| Acasti Pharma Inc. | -23 Million USD | -452.774% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -3676.567% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -682.588% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 7.677% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -3980.58% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -471.994% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -584.828% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 24.878% |
| PepGen Inc. | -60.67 Million USD | -109.602% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -453.472% |
| United Therapeutics Corporation | -507.7 Million USD | 74.953% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -564.884% |
| Solid Biosciences Inc. | -47.75 Million USD | -166.316% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -14650.873% |
| Immuneering Corporation | -54.94 Million USD | -131.451% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2925.241% |
| Silo Pharma, Inc. | -3.52 Million USD | -3508.245% |
| Belite Bio, Inc | -87.27 Million USD | -45.714% |
| XOMA Corporation | -29 Million USD | -338.502% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -79.874% |
| Bionomics Limited | 227 Million USD | 156.018% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -9.36% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -4920.358% |
| uniQure N.V. | -102.95 Million USD | -23.521% |
| Cassava Sciences, Inc. | -121.13 Million USD | -4.978% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2952.883% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 410.531% |
| Forte Biosciences, Inc. | -11.96 Million USD | -963.169% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -4009.807% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 120067.6% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3821.235% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1528.025% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1614.747% |
| Altimmune, Inc. | -134.48 Million USD | 5.444% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 164.204% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -4920.358% |
| Compugen Ltd. | -12.9 Million USD | -885.475% |
| Peak Bio, Inc. | 10.34 Million USD | 1329.823% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -44834.861% |
| Benitec Biopharma Inc. | -50.58 Million USD | -151.405% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -21.879% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 747.318% |
| Zura Bio Limited | -99.8 Million USD | -27.413% |
| PolyPid Ltd. | 6.17 Million USD | 2161.032% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 271.567% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 747.318% |
| Instil Bio, Inc. | 75.35 Million USD | 268.749% |
| argenx SE | -2.02 Billion USD | 93.732% |
| Immunome, Inc. | -97.02 Million USD | -31.059% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -465.306% |
| Verona Pharma plc | -220.44 Million USD | 42.314% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -77.252% |
| Shattuck Labs, Inc. | -121.42 Million USD | -4.729% |
| CervoMed Inc. | -7.79 Million USD | -1531.826% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 31.447% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2807.973% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 3.472% |
| Moolec Science SA | 117.61 Thousand USD | 108219.351% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -5457.995% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 899.865% |
| AnaptysBio, Inc. | -18.15 Million USD | -600.599% |
| Design Therapeutics, Inc. | -18.15 Million USD | -600.637% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -80.682% |
| NeurAxis, Inc. | 145.7 Thousand USD | 87379.105% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1232.173% |
| Lumos Pharma, Inc. | -28.49 Million USD | -346.305% |
| Achilles Therapeutics plc | -126.92 Million USD | -0.19% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -77.252% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -19292.99% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -512.144% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 8821.165% |
| Nutriband Inc. | -251.65 Thousand USD | -50431.341% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -865.497% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1609.216% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 137.38% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 635.773% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 71.581% |
| Palisade Bio, Inc. | -12.06 Million USD | -954.179% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 9.369% |
| Beam Therapeutics Inc. | -262.72 Million USD | 51.597% |
| Neurogene Inc. | -131.95 Million USD | 3.63% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 682.901% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2505.854% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 66.286% |
| Sesen Bio, Inc. | -112.55 Million USD | -12.983% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -27.344% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -5316.391% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -225.849% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -52.693% |
| Athira Pharma, Inc. | -88.99 Million USD | -42.884% |
| Vaccinex, Inc. | -1.28 Million USD | -9773.11% |
| HCW Biologics Inc. | 2.85 Million USD | 4551.525% |
| XOMA Corporation | -29 Million USD | -338.502% |
| Nektar Therapeutics | 210.24 Million USD | 160.486% |
| Arvinas, Inc. | -313.8 Million USD | 59.476% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 7935.753% |
| Merus N.V. | -192.88 Million USD | 34.071% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 311.996% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1732.886% |
| Rezolute, Inc. | -68.16 Million USD | -86.547% |
| Clene Inc. | 3.34 Million USD | 3907.355% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -864.326% |
| BeyondSpring Inc. | -13.75 Million USD | -824.505% |
| Synlogic, Inc. | -6.68 Million USD | -1802.254% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 11313.903% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1404.029% |
| Peak Bio, Inc. | 10.34 Million USD | 1329.823% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -54.29% |
| Krystal Biotech, Inc. | -350.23 Million USD | 63.691% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 202.45% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 24.752% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -3927.87% |
| MannKind Corporation | 143.89 Million USD | 188.371% |
| Ikena Oncology, Inc. | -109.15 Million USD | -16.499% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1579.641% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -284.186% |
| Gossamer Bio, Inc. | 180.35 Million USD | 170.509% |
| CohBar, Inc. | -5.93 Million USD | -2044.182% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -327.476% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2885.056% |
| Legend Biotech Corporation | -949.39 Million USD | 86.606% |
| Mural Oncology plc | -255.84 Million USD | 50.295% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 494.741% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -2599.54% |
| Disc Medicine, Inc. | -358.28 Million USD | 64.507% |
| Champions Oncology, Inc. | 4.81 Million USD | 2742.678% |
| REGENXBIO Inc. | 54.76 Million USD | 332.19% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -47189.827% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 15.798% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1311.069% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -57.611% |
| Vaxart, Inc. | -8.24 Million USD | -1443.085% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -153.419% |
| Cellectis S.A. | -43.85 Million USD | -189.968% |
| Longeveron Inc. | -2.9 Million USD | -4272.959% |
| Repare Therapeutics Inc. | -107.85 Million USD | -17.901% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 113.132% |
| Inozyme Pharma, Inc. | 12 Million USD | 1159.361% |
| Revolution Medicines, Inc. | -608.2 Million USD | 79.092% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -10238.671% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 52.034% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 15.264% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -712.716% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -17084.548% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.67% |
| Denali Therapeutics Inc. | -74.86 Million USD | -69.86% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -960.447% |
| Veru Inc. | 4.77 Million USD | 2760.387% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1030.763% |
| Cingulate Inc. | 3.08 Million USD | 4225.162% |
| Passage Bio, Inc. | 4.58 Million USD | 2873.515% |
| Context Therapeutics Inc. | -14.44 Million USD | -780.05% |
| Exicure, Inc. | 5.84 Million USD | 2274.144% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 44.801% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -221.369% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 910.437% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -116.191% |
| Nuvalent, Inc. | -335.38 Million USD | 62.084% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 7432.218% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -70.733% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1330.435% |
| OmniAb, Inc. | 9.2 Million USD | 1481.785% |
| Anew Medical, Inc. | 1.43 Million USD | 8977.401% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 876.264% |
| Lipocine Inc. | -4.75 Million USD | -2574.586% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -15.786% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 934.913% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -151.023% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 610.87% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1792.065% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -93.182% |
| Ocugen, Inc. | -32.52 Million USD | -291.026% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -48.601% |
| Q32 Bio Inc. | -37.94 Million USD | -235.105% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -20149.308% |
| Alumis Inc. Common Stock | -13.52 Million USD | -839.949% |
| Equillium, Inc. | -22.39 Million USD | -467.907% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -397.363% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -289.759% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -51194.055% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 194.87% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 4076.412% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 38817.96% |
| Dominari Holdings Inc. | 195 Thousand USD | 65313.157% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2314.426% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1326.104% |
| Bio-Techne Corporation | 267.74 Million USD | 147.495% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -684.537% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -7.682% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1413.336% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -905.183% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 48.121% |
| Nkarta, Inc. | 57.29 Million USD | 321.933% |
| BioCardia, Inc. | 212 Thousand USD | 60083.8% |
| Iterum Therapeutics plc | 13.43 Million USD | 1046.314% |